Day One Biopharmaceutical Stock (NASDAQ: DAWN)

Day One Biopharmaceutical (NASDAQ:DAWN) Stock, Unusual Options

Day One Biopharmaceutical

Day One Biopharmaceuticals, Inc. - Common Stock

Overview

News

Earnings

Options

Analyst Ratings

Insider Trades

Short Interest

Stock Report

Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY101, is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, and kinase inhibitor.

Comments

Day One Biopharmaceutical Unusual Options